Marsh & McLennan Companies (MMC)
(Delayed Data from NYSE)
$219.10 USD
+0.86 (0.39%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $219.11 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$219.10 USD
+0.86 (0.39%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $219.11 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth F Momentum F VGM
Zacks News
Will Rising Costs Hurt Marsh & McLennan's (MMC) Q1 Earnings?
by Zacks Equity Research
Marsh & McLennan's (MMC) first-quarter results are likely to reflect decreasing rates in Workers' compensation and financial and professional liability rates and rising expenses.
Brown & Brown (BRO) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Brown & Brown (BRO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
AON & ReliaQuest Enhance Offerings in Cyber Risk Management
by Zacks Equity Research
AON collaborates with ReliaQuest to strengthen its foothold in the cyber risk management space.
Marsh & McLennan (MMC) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Marsh & McLennan (MMC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Marsh & McLennan (MMC) Unit Unveils Oliver Wyman Vector
by Zacks Equity Research
Marsh & McLennan (MMC) combines its CAVOK division and recently acquired SeaTec Consulting into Oliver Wyman Vector.
Arch Capital (ACGL) Unit to Expand in Middle-Market P&C Segment
by Zacks Equity Research
Arch Capital (ACGL) unit, Arch Insurance North America, sets sights on expansion, acquiring Allianz's U.S. MidCorp and Entertainment insurance businesses for $450 million cash.
Assurant (AIZ) Bolsters UK Presence With iSmash Acquisition
by Zacks Equity Research
Assurant's (AIZ) latest acquisition of iSmash, the UK's premier tech repair brand, signals a strategic move to dominate the drop-in repair market.
Arthur J. Gallagher (AJG) Expands With Strategic Acquisition
by Zacks Equity Research
Arthur J. Gallagher's (AJG) buyout of Specialty Risk Management Services strengthens its position as a leading global insurance brokerage and risk management firm.
Compelling Reasons to Hold on to Marsh & McLennan (MMC) Stock
by Zacks Equity Research
Marsh & McLennan (MMC) gains from strong segmental contribution, better rate hikes and solid growth in operating cash flows.
Brown & Brown (BRO) Strengthens Portfolio With DealerMax
by Zacks Equity Research
Brown & Brown's (BRO) buyout of DealerMax is likely to strengthen the insurance broker's capabilities and expand its presence in Pennsylvania.
Brown & Brown (BRO) Buys Hillco Insurance, Boosts Portfolio
by Zacks Equity Research
Brown & Brown's (BRO) buyout of Hillco Insurance is likely to strengthen the insurance broker's capabilities and expand its presence in Dallas.
Marsh & McLennan (MMC) Unit Buys Firms to Enhance Capabilities
by Zacks Equity Research
Marsh & McLennan (MMC) unit MMA acquires Louisiana-based Q&N and Louisiana Companies to better serve its midsize client base and boost its statewide footprint.
Marsh & McLennan's (MMC) Mercer SelectRx to Lower Pharmacy Spend
by Zacks Equity Research
Marsh & McLennan's (MMC) sub-unit Mercer launches a tech-enabled solution to generate higher cost savings for employees on specialty drugs and subsequently, drive its revenues.
Top Research Reports for Merck, ServiceNow & Blackstone
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), ServiceNow, Inc. (NOW) and Blackstone Inc. (BX).
Willis Towers (WTW) Q4 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
Willis Towers (WTW) fourth-quarter results reflect higher revenues and expanded operating margins at the Health, Wealth & Career and Risk & Broking segments, offset by higher expenses.
5 Insurance Brokers to Watch on Increased Business Activity
by Tanuka De
Increased demand for insurance products, given an aging population, baby boomers and millennials, and the adoption of technology should drive insurance brokers like MMC, AON, AJG, WTW and BRO.
MetLife (MET) Q4 Earnings Miss on High Costs & Weak EMEA Unit
by Zacks Equity Research
MetLife's (MET) Q4 results took a hit from increased policyholder benefits and claims, partly offset by expanding volumes in the Group Benefits and Latin America units.
HCA Healthcare's (HCA) Q4 Earnings Beat on Improved Admissions
by Zacks Equity Research
HCA Healthcare (HCA) expects EPS in the range of $19.70-$21.20 for 2024, the midpoint being 7.6% higher than the 2023 figure.
Is a Beat in Store for Chubb Limited (CB) in Q4 Earnings?
by Zacks Equity Research
Chubb Limited's (CB) performance is likely to have benefited from rate increases, favorable prior period reserve development and strong renewal retention.
Arthur J. Gallagher (AJG) Q4 Earnings & Revenues Top, Up Y/Y
by Zacks Equity Research
Arthur J. Gallagher's (AJG) fourth-quarter results reflect higher adjusted revenues and margin expansion across the Brokerage and Risk Management segments.
Marsh & McLennan (MMC) Q4 Earnings Beat on Solid US Business
by Zacks Equity Research
Marsh & McLennan's (MMC) fourth-quarter results benefit from expanding operations across Latin America and EMEA, partly offset by higher operating expenses.
Compared to Estimates, Marsh & McLennan (MMC) Q4 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Marsh & McLennan (MMC) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Marsh & McLennan (MMC) Q4 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Marsh & McLennan (MMC) delivered earnings and revenue surprises of 5% and 0.62%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Marsh & McLennan (MMC) Ahead of Earnings?
by Zacks Equity Research
Marsh & McLennan (MMC) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Exploring Analyst Estimates for Marsh & McLennan (MMC) Q4 Earnings, Beyond Revenue and EPS
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Marsh & McLennan (MMC), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.